Vicore Pharma (Sweden) Today
| VICO Stock | SEK 7.91 0.13 1.67% |
Performance0 of 100
| Odds Of DistressOver 64
|
Vicore Pharma is selling for under 7.91 as of the 23rd of November 2024; that is 1.67% up since the beginning of the trading day. The stock's last reported lowest price was 7.65. Vicore Pharma has more than 64 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Vicore Pharma Holding are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of December 2022 and ending today, the 23rd of November 2024. Click here to learn more.
Vicore Pharma Holding AB , through its subsidiaries, operates as a biotech company. Vicore Pharma Holding AB was founded in 2000 and is based in Mlndal, Sweden. Vicore Pharma is traded on Stockholm Stock Exchange in Sweden. The company has 81.85 M outstanding shares. More on Vicore Pharma Holding
Moving together with Vicore Stock
Moving against Vicore Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Vicore Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Vicore Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Vicore Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Vicore Pharma Holding (VICO) is traded on Stockholm Exchange in Sweden and employs 23 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.26 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vicore Pharma's market, we take the total number of its shares issued and multiply it by Vicore Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Vicore Pharma Holding operates under Healthcare sector and is part of Biotechnology industry. The entity has 81.85 M outstanding shares.
Vicore Pharma Holding has accumulated about 215.97 M in cash with (265.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.1.
Check Vicore Pharma Probability Of Bankruptcy
Ownership AllocationVicore Pharma Holding shows a total of 81.85 Million outstanding shares. Over half of Vicore Pharma's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Vicore Pharma Holding. Please watch out for any change in the institutional holdings of Vicore Pharma as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Vicore Ownership Details
Vicore Pharma Holding Risk Profiles
Although Vicore Pharma's alpha and beta are two of the key measurements used to evaluate Vicore Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.65 | |||
| Standard Deviation | 6.71 | |||
| Variance | 45.08 | |||
| Risk Adjusted Performance | (0.08) |
Vicore Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Vicore Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
| All Next | Launch Module |
Vicore Pharma Corporate Management
Elected by the shareholders, the Vicore Pharma's board of directors comprises two types of representatives: Vicore Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vicore. The board's role is to monitor Vicore Pharma's management team and ensure that shareholders' interests are well served. Vicore Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vicore Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kicki Johansson | Chief Officer | Profile | |
| Johan Raud | Chief Officer | Profile | |
| Elin Rosendahl | VP Devel | Profile | |
| Nina Carlen | Chief Officer | Profile | |
| Asa Magnusson | Chief Officer | Profile | |
| Rohit Batta | Chief Officer | Profile | |
| Hans Jeppsson | Chief Officer | Profile |
Additional Tools for Vicore Stock Analysis
When running Vicore Pharma's price analysis, check to measure Vicore Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicore Pharma is operating at the current time. Most of Vicore Pharma's value examination focuses on studying past and present price action to predict the probability of Vicore Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicore Pharma's price. Additionally, you may evaluate how the addition of Vicore Pharma to your portfolios can decrease your overall portfolio volatility.